Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Mati Therapeutics develops a non-invasive sustained drug delivery platform, the Evolute Punctal Plug Delivery System, for treating ocular diseases such as glaucoma. The device delivers medication over an extended period, removing the need for patients to administer eye drops.
0 investors
Matinas BioPharma develops a Lipid Nano-Crystal (LNC) drug delivery platform that enables oral, intracellular delivery of small molecules and oligonucleotides. Its lead product MAT2203 is an amphotericin B formulation, alongside discovery programs in oncology and inflammation.
0 investors
0 investors
0 investors
0 investors
Maverix Oncology develops conditionally activated small molecule therapeutics for cancer treatment, led by a team of oncologists and cancer scientists with experience in drug discovery and development.
0 investors
0 investors
MAXONA Pharmaceuticals develops non-opioid pain treatment options for the U.S. market. The company is focused on expanding therapeutic alternatives in pain management.
0 investors
Maxymune is a pharmaceutical company developing treatments for immunological diseases, including a small-molecule LAT1 inhibitor program targeting overactive T-cells in autoimmune conditions and an improved formulation of mycophenolic acid intended to reduce gastrointestinal side effects. Its work spans drug discovery and formulation of immunosuppressive therapies for patients with immunological disorders.
0 investors
0 investors
0 investors
MBF Therapeutics (MBFT) is an animal health biotechnology company developing veterinary vaccines through its T-Max platform, which combines full-length natural antigen screening, deep T-cell and B-cell immune profiling, and calcium phosphate nanoparticle delivery (CaptaVax). The company structures the immunological data from its in vitro and in vivo studies for machine learning, with the aim of training predictive immunology models; it also has a human health spinout, TeraVax Biotech.
0 investors
MBQ Pharma develops precision therapeutics that target Rac and CDC42 GTPases for cancer, autoimmune, and fibrotic diseases, with a lead compound (MBQ-167) aimed at preventing and removing metastases. Its lead candidate is in a Phase 1 study, based on IP licensed from the University of Puerto Rico.
0 investors
MD Hyperbaric operates medically-supervised hyperbaric oxygen therapy (HBOT) centers nationwide, treating conditions including chronic wounds and neurological injuries by delivering oxygen in pressurized environments. The company serves patients seeking non-invasive therapeutic treatment for healing and recovery.
0 investors
0 investors
MDI Therapeutics is a pharmaceutical company developing small molecule therapies for fibrosis and fibroproliferative diseases, including MDI-2517, an inhibitor of plasminogen activator inhibitor 1 (PAI-1) currently in a Phase 1 clinical study. It operates in the biotech and drug development space.
0 investors
MDM Wound Ventures develops evidence-based wound care solutions, including products based on medicinal honey research, for clinicians treating homecare patients. It focuses on advancing wound healing with reduced patient pain.
0 investors
0 investors
0 investors
0 investors
0 investors